Drug | Comparison | Pearson r correlation | Spearman r correlation | Reference |
---|---|---|---|---|
Infliximab | Sanquin RIA–Leuven ELISA | 0.95 | – | 35 |
Sanquin RIA–Theradiag ELISA | 0.99 | – | ||
Leuven ELISA–Theradiag ELISA | 0.97 | – | ||
Infliximab | Biomonitor RIA–Prometheus ELISA | 0.82 | 0.64 | 36 |
Biomonitor RIA–Prometheus HMSA | 0.77 | 0.81 | ||
Biomonitor RIA–RGA | 0.80 | 0.67 | ||
RGA–Prometheus ELISA | 0.96 | 0.78 | ||
RGA–Prometheus HMSA | 0.78 | 0.58 | ||
Prometheus ELISA–Prometheus HMSA | 0.81 | 0.54 | ||
Infliximab | ELISA–RIA | 0.73 | – | 37 |
ELISA–RGA | 0.93 | |||
ELISA–EIA | 0.89 | |||
RIA–RGA | 0.75 | – | ||
RIA–EIA | 0.71 | – | ||
RGA–EIA | 0.93 | – | ||
Infliximab | Promonitor ELISA–Sanquin RIA | 0.973 | – | 38 |
Adalimumab | Promonitor ELISA–Sanquin RIA | 0.996 | – | 38 |
EIA, enzyme immunoassay; HMSA, homogenous mobility shift assay; RGA, reporter gene assay; RIA, radioimmunoassay.